A huge benefit to the research community
On December 20, 2024, Eli Lilly announced the FDA has approved Zepbound (tirzepatide) as the first and only prescription medication for adults with moderate-to-severe obstructive sleep apnea and obesity. AASM.org Among persons with moderate-to-severe obstructive sleep apnea and obesity, tirzepatide reduced the AHI, body weight, hypoxic burden, hsCRP concentration, and systolic blood pressure and improved sleep-related patient-reported outcomes. NIH study Can the makers of these new weight loss medications really claim to treat and cure Obstructive Sleep Apnea (OSA)
Thank you to our sponsors AG1: David: Function: Rorra: Timestamps (00:00:00) Tommy Wood (00:04:05) Neuroplasticity
Hydration and Indian summers Diarrhoea, vomiting, or reduced intake on GLP-1s can quickly lead to dehydration and kidney stress in hot weather
Effective Anesthesia with Flexible Use: Widely used for producing anesthesia in a range of clinical scenarios, including surgical and emergency settings
Upphr: Session Namn: kdid Ansvarig: .klarna.com Utfrdare: Beskrivning: Anvnds av Klarna